从急性淋巴细胞白血病转变为PDGFRB突变的急性髓性白血病在异构干细胞移植后
Clinical laboratory
|February 19, 2025
概括
干细胞移植后急性T-淋巴细胞白血病 (T-ALL) 转化为急性髓性白血病 (AML) 表明预后不佳. 综合性评估对于指导治疗和评估复发性白血病的结果至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 干细胞移植 干细胞移植
背景情况:
- 研究急性T-淋巴细胞白血病 (T-ALL) 转化为急性髓性白血病 (AML) 的研究.
- 为改善T-ALL转化为AML的临床诊断和治疗策略奠定基础.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Bone Marrow Sampling and Transplants
275
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
275


